MAXORIF
MRP: 185
Packaging: 60ml
Pack Type: suspension
Composition:
Rifaximin 100mg
Indication:
Non-Invasive Travelers Diarrhea, Hepatic Encephalopathy, Irritable Bowel Syndrome.
Description:
Rifaximin 100 mg is a gut-selective, non-systemic antibiotic effective against a wide range of gastrointestinal infections. It works by inhibiting bacterial RNA synthesis and is used for treating traveler’s diarrhea, hepatic encephalopathy (as adjunct), and small intestinal bacterial overgrowth (SIBO). Its minimal systemic absorption ensures a low risk of side effects and drug interactions.
Tags:
- Effective against GI pathogens causing diarrhea
- Minimally absorbed – acts locally in the gut
- Suitable for both adults and children (pediatric-friendly dose)
- Fewer systemic side effects
- Useful in SIBO and hepatic encephalopathy as adjunct
Usage Information
Dosage
Pediatric (based on weight): As directed by physician, typically 100 mg 2–3 times daily Adults: Typically 200–400 mg 2–3 times/day, depending on indication Shake well before use (if suspension) Administer with or without food
Side Effects
Abdominal pain, nausea, flatulence Headache or dizziness (rare) Rash or hypersensitivity reactions (very rare) Overuse may lead to resistance
Contraindications
Known hypersensitivity to rifaximin or rifamycin-class antibiotics Severe hepatic impairment without physician monitoring Diarrhea due to non-bacterial causes (e.g., viral)
Availability
Rifaximin 100 mg, gut antibiotic, rifaximin syrup, rifaximin for diarrhea, pediatric GI antibiotic, SIBO treatment, rifaximin oral suspension